Schneditz Daniel, Ribitsch Werner, Schilcher Gernot, Uhlmann Matthias, Chait Yossi, Stadlbauer Vanessa
Institute of Physiology, Medical University of Graz, Graz, Austria.
Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.
Hemodial Int. 2016 Jan;20(1):120-8. doi: 10.1111/hdi.12338. Epub 2015 Aug 5.
Central hematocrit (H) measurements are currently used to track the degree of ultrafiltration-induced hemoconcentration with the aim to detect and prevent excessive intravascular fluid depletion during hemodialysis (HD). Failure to maintain hemodynamic stability is commonly attributed to the misinterpretation of H caused by an unaccountable increase in Fcells , the ratio of whole-body hematocrit to H. It was the aim to examine Fcells under everyday conditions in a group of stable HD patients. Absolute plasma volume (Vp ) and H were concomitantly measured during routine HD in the extracorporeal system in hourly intervals by noninvasive and continuous technology (CritLine-Instrument-III) and indocyanine green dye dilution to derive relative plasma volumes from Vp and H (RPVp , RPVH ), respectively, and to calculate Fcells . Thirteen patients were studied during two midweek treatments (n = 26). Both absolute Vp (P < 0.05) and relative plasma volumes RPVH (P < 0.001) decreased during HD. Vp at any time point was positively correlated to RPVH (r = 0.52). Moreover, relative plasma volumes RPVH and RPVp determined by independent techniques were identical and showed negligible bias (-0.2%) but considerable limits of agreement (-15.6% to +15.3%). Fcells was stable and in the range of 0.9 ± 0.05 throughout HD and not different from the value assumed at the beginning of HD. Although Fcells remains constant in patients on routine dialysis and relative plasma volumes (RPVH and RPVp ) determined by independent techniques are therefore comparable, the variability of experimental conditions during dialysis and the limited accuracy of absolute volume measurements using available technology continues to complicate the ultrafiltration control problem.
目前,中心血细胞比容(H)测量用于追踪超滤引起的血液浓缩程度,目的是在血液透析(HD)期间检测并预防血管内液体过度消耗。未能维持血流动力学稳定性通常归因于Fcells(全身血细胞比容与H的比值)出现无法解释的增加而导致对H的错误解读。本研究旨在检查一组稳定的HD患者在日常情况下的Fcells。在常规HD期间,通过无创连续技术(CritLine-Instrument-III)和吲哚菁绿染料稀释法,每小时体外系统中同时测量绝对血浆量(Vp)和H,分别从Vp和H得出相对血浆量(RPVp、RPVH),并计算Fcells。在两次周三治疗期间对13名患者进行了研究(n = 26)。HD期间绝对Vp(P < 0.05)和相对血浆量RPVH(P < 0.001)均下降。任何时间点的Vp与RPVH呈正相关(r = 0.52)。此外,通过独立技术测定的相对血浆量RPVH和RPVp相同,偏差可忽略不计(-0.2%),但一致性界限相当大(-15.6%至+15.3%)。在整个HD过程中,Fcells稳定,范围为0.9±0.05,与HD开始时假定的值无差异。尽管在常规透析患者中Fcells保持恒定,因此通过独立技术测定的相对血浆量(RPVH和RPVp)具有可比性,但透析期间实验条件的变异性以及使用现有技术进行绝对体积测量的有限准确性,继续使超滤控制问题复杂化。